199 related articles for article (PubMed ID: 10893293)
21. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
González MB; Hernández JM; García JL; Lumbreras E; Castellanos M; Hernández JM; Fernández-Calvo J; Gutiérrez NC; San Miguel JF
Haematologica; 2004 Oct; 89(10):1213-8. PubMed ID: 15477206
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.
Parry-Jones N; Matutes E; Morilla R; Brito-Babapulle V; Wotherspoon A; Swansbury GJ; Catovsky D
Br J Haematol; 2007 Apr; 137(2):117-24. PubMed ID: 17391491
[TBL] [Abstract][Full Text] [Related]
23. Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.
Kim SH; Cheong JW; Park KH; Kim TS; Yang WI
Arch Pathol Lab Med; 2007 Mar; 131(3):457-67. PubMed ID: 17516749
[TBL] [Abstract][Full Text] [Related]
24. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
[TBL] [Abstract][Full Text] [Related]
25. Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma.
Katz RL; Caraway NP; Gu J; Jiang F; Pasco-Miller LA; Glassman AB; Luthra R; Hayes KJ; Romaguera JE; Cabanillas FF; Medeiros LJ
Am J Clin Pathol; 2000 Aug; 114(2):248-57. PubMed ID: 10941340
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma.
Stilgenbauer S; Winkler D; Ott G; Schaffner C; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
Blood; 1999 Nov; 94(9):3262-4. PubMed ID: 10556216
[TBL] [Abstract][Full Text] [Related]
27. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903
[TBL] [Abstract][Full Text] [Related]
28. Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma.
Lossos IS; Thorstenson YR; Wayne TL; Oefner PJ; Levy R; Chu G
Leuk Lymphoma; 2002 May; 43(5):1079-85. PubMed ID: 12148890
[TBL] [Abstract][Full Text] [Related]
29. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
[TBL] [Abstract][Full Text] [Related]
30. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
Greipp PT; Smoley SA; Viswanatha DS; Frederick LS; Rabe KG; Sharma RG; Slager SL; Van Dyke DL; Shanafelt TD; Tschumper RC; Zent CS
Br J Haematol; 2013 Nov; 163(3):326-33. PubMed ID: 24032430
[TBL] [Abstract][Full Text] [Related]
31. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
Koduru PR; Chen W; Garcia R; Fuda F
Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Piva N; Milani R; Bullrich F; Veronese ML; Croce C; Birg F; Döhner H; Hagemeijer A; Castoldi G
Blood; 1999 Feb; 93(4):1372-80. PubMed ID: 9949181
[TBL] [Abstract][Full Text] [Related]
33. Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event.
Lespinet V; Terraz F; Recher C; Campo E; Hall J; Delsol G; Al Saati T
Int J Cancer; 2005 May; 114(6):909-16. PubMed ID: 15645496
[TBL] [Abstract][Full Text] [Related]
34. A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia.
Gardiner A; Parker H; Glide S; Mould S; Robinson H; Tracy I; Stankovic T; Oscier D; Strefford J
Leuk Res; 2012 Mar; 36(3):307-10. PubMed ID: 21955805
[TBL] [Abstract][Full Text] [Related]
35. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.
Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN
Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040
[TBL] [Abstract][Full Text] [Related]
36. Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.
Gallo M; Cacheux V; Vincent L; Bret C; Tempier A; Guittard C; Macé A; Leventoux N; Costes V; Szablewski V
Virchows Arch; 2016 Dec; 469(6):697-706. PubMed ID: 27605053
[TBL] [Abstract][Full Text] [Related]
37. Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.
Yamamoto K; Lee BJ; Li C; Dubois RL; Hobeika E; Bhagat G; Zha S
Leukemia; 2015 Jun; 29(6):1414-24. PubMed ID: 25676421
[TBL] [Abstract][Full Text] [Related]
38. [Cytogenetics of mantle cell lymphoma].
Obukhova TN; Lorie IuIu; Vodinskaia LA; Alimova GA; Nikitin EA; Samoĭlova RS; Kaplanskaia IB; Domracheva EV
Ter Arkh; 2004; 76(7):70-7. PubMed ID: 15379132
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
[TBL] [Abstract][Full Text] [Related]
40. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
